NCT06932302

Brief Summary

This pilot study investigates the regular use of non-invasive dorsal genital nerve stimulation (DGS) for the treatment of female sexual dysfunction (FSD). The researchers aim to determine whether subjects with FSD can correctly follow an at-home treatment regimen and to demonstrate that DGS can improve FSD arousal symptoms in premenopausal and postmenopausal women. Some subjects will use a smart vibrator for comparison to DGS.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
18mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Oct 2025Nov 2027

First Submitted

Initial submission to the registry

April 9, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

October 15, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

April 9, 2025

Last Update Submit

December 16, 2025

Conditions

Keywords

dorsal genital nerve stimulationneuromodulation

Outcome Measures

Primary Outcomes (2)

  • Number of dorsal genital nerve stimulation (DGS) sessions performed

    Approximately day 22

  • Number of related adverse events

    Study-related AEs include incidents such as device zapping, skin irritation, back cramps, or falls due to sitting for 30 minutes of stimulation.

    Up to week 9

Secondary Outcomes (2)

  • Change in Female Sexual Function Index (FSFI) total scores

    Baseline and approximately day 22

  • The Patient Global Impression of Change (PGIC) survey score

    Up to week 9

Study Arms (3)

Nerve Stimulation only

EXPERIMENTAL

Pre-menopausal women and post-menopausal women will be recruited. Individuals in this group will only perform dorsal genital nerve stimulation.

Device: Electrical Stimulation

Nerve Stimulation and Vibration

EXPERIMENTAL

Pre-menopausal women and post-menopausal women will be recruited. Individuals in this group will perform dorsal genital nerve stimulation and use a smart vibrator.

Device: Electrical StimulationDevice: Smart vibrator

Vibration only

ACTIVE COMPARATOR

Pre-menopausal women and post-menopausal women will be recruited. Individuals in this group will only use a smart vibrator.

Device: Smart vibrator

Interventions

Subjects will use a smart vibrator at home twice a week during the study. The Lioness smart vibrator records physiological responses during use.

Nerve Stimulation and VibrationVibration only

Electrical stimulation of the dorsal genital nerve will be accomplished using the UCon system and patch electrodes developed by InnoCon. The UCon system includes a programmable control unit; leads that connect to the control unit and electrodes; a silicone surface electrode; a reference electrode; and a remote control for quick on and off toggling of stimulation.

Also known as: UCon patch system
Nerve Stimulation and VibrationNerve Stimulation only

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Capable of speaking and understanding English.
  • Able to comprehend the clinical study procedures and provide informed consent.
  • Identified as having female sexual dysfunction with a Female Sexual Function Index (FSFI) score of 26.55 or less and a score of 3 or less on one or more of the FSFI subdomains of lubrication, arousal, and orgasm.
  • Willing and able to adhere to the study protocol
  • Able to attend experimental sessions at Michigan Medicine at both the start and conclusion of the study.

You may not qualify if:

  • Not currently sexually active.
  • Pregnant or planning to get pregnant during the study period.
  • History of a neurological disorder or impairments affecting pelvic organ function, including diagnosed with dorsal genital nerve damage, lower motor dysfunction, or other related conditions.
  • Implanted with a neurostimulator for bladder or bowel function.
  • Have a skin condition that would predispose them to sensitivity to the stimulation electrodes.
  • Female sexual dysfunction limited solely to low desire, without issues in lubrication, arousal, or orgasm.
  • Clinically diagnosed bladder dysfunction, pelvic pain, or other pelvic organ symptoms; or a score of 8 or higher on the American Urological Association Symptom Index (AUASI).
  • Unable or unwilling to adhere to the study protocol
  • Simultaneously participating in another research study that may affect the results of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

RECRUITING

MeSH Terms

Interventions

Electric Stimulation

Intervention Hierarchy (Ancestors)

Physical StimulationInvestigative Techniques

Study Officials

  • Tim Bruns, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR
  • Priyanka Gupta, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tim Bruns, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Biomedical Engineering

Study Record Dates

First Submitted

April 9, 2025

First Posted

April 17, 2025

Study Start

October 15, 2025

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations